Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drew Provan

Showing results (31-40 of 85) with videos related to

Pageof 9
Sort By:
Diagnostics (Basel, Switzerland)|July 13, 2024
Can Machine Learning Assist in Diagnosis of Primary Immune Thrombocytopenia? A Feasibility StudyHaroon Miah, Dimitrios Kollias, Giacinto Luca Pedone, et al.
Hematology (Amsterdam, Netherlands)|October 8, 2003
In vitro cytotoxic effects of stabilizing sugars within human intravenous immunoglobulin preparations against the human macrophage THP-1 cell-lineMarc A Williams, Chris J Rhoades, Drew Provan, et al.
European Journal of Haematology|May 21, 2016
Thromboembolism in adults with primary immune thrombocytopenia: a systematic literature review and meta-analysisIndraraj Umesh Doobaree, Raghava Nandigam, Dimitri Bennett, et al.
Plos Medicine|January 13, 2006
Long-term outcome of otherwise healthy individuals with incidentally discovered borderline thrombocytopeniaRoberto Stasi, Sergio Amadori, John Osborn, et al.
American Journal of Hematology|December 22, 2005
Efficacy of mycophenolate mofetil as single-agent therapy for refractory immune thrombocytopenic purpuraDrew Provan, Ashley J Moss, Adrian C Newland, et al.
BMJ (Clinical Research Ed.)|October 22, 2008
Prescribing intravenous immunoglobulin: summary of Department of Health guidelinesDrew Provan, Helen M Chapel, W A Carrock Sewell, et al.
Advances in Therapy|August 20, 2024
Tapering and Sustained Remission of Thrombopoietin Receptor Agonists (TPO-RAs): Is it Time for Paediatric ITP?Susana Marcos-Peña, Beatriz Fernández-Pernia, Drew Provan, et al.
European Journal of Haematology|October 23, 2009
Treatment practices in adults with chronic immune thrombocytopenia - a European perspectiveFrancesco Rodeghiero, Juan Besalduch, Marc Michel, et al.
British Journal of Haematology|April 17, 2004
Alpha-galactosylceramide-driven expansion of human natural killer T cells is inhibited by prednisolone treatmentUlrika Johansson, Marion G Macey, Deborah Kenny, et al.
The American Journal of Medicine|April 6, 2005
Helicobacter pylori eradication in the management of patients with idiopathic thrombocytopenic purpuraRoberto Stasi, Zaccaria Rossi, Elisa Stipa, et al.
Pageof 9

Showing results (31-40 of 85) with videos related to

Sort By:
Pageof 9
Diagnostics (Basel, Switzerland)|July 13, 2024
Can Machine Learning Assist in Diagnosis of Primary Immune Thrombocytopenia? A Feasibility StudyHaroon Miah, Dimitrios Kollias, Giacinto Luca Pedone, et al.
Hematology (Amsterdam, Netherlands)|October 8, 2003
In vitro cytotoxic effects of stabilizing sugars within human intravenous immunoglobulin preparations against the human macrophage THP-1 cell-lineMarc A Williams, Chris J Rhoades, Drew Provan, et al.
European Journal of Haematology|May 21, 2016
Thromboembolism in adults with primary immune thrombocytopenia: a systematic literature review and meta-analysisIndraraj Umesh Doobaree, Raghava Nandigam, Dimitri Bennett, et al.
Plos Medicine|January 13, 2006
Long-term outcome of otherwise healthy individuals with incidentally discovered borderline thrombocytopeniaRoberto Stasi, Sergio Amadori, John Osborn, et al.
American Journal of Hematology|December 22, 2005
Efficacy of mycophenolate mofetil as single-agent therapy for refractory immune thrombocytopenic purpuraDrew Provan, Ashley J Moss, Adrian C Newland, et al.
BMJ (Clinical Research Ed.)|October 22, 2008
Prescribing intravenous immunoglobulin: summary of Department of Health guidelinesDrew Provan, Helen M Chapel, W A Carrock Sewell, et al.
Advances in Therapy|August 20, 2024
Tapering and Sustained Remission of Thrombopoietin Receptor Agonists (TPO-RAs): Is it Time for Paediatric ITP?Susana Marcos-Peña, Beatriz Fernández-Pernia, Drew Provan, et al.
European Journal of Haematology|October 23, 2009
Treatment practices in adults with chronic immune thrombocytopenia - a European perspectiveFrancesco Rodeghiero, Juan Besalduch, Marc Michel, et al.
British Journal of Haematology|April 17, 2004
Alpha-galactosylceramide-driven expansion of human natural killer T cells is inhibited by prednisolone treatmentUlrika Johansson, Marion G Macey, Deborah Kenny, et al.
The American Journal of Medicine|April 6, 2005
Helicobacter pylori eradication in the management of patients with idiopathic thrombocytopenic purpuraRoberto Stasi, Zaccaria Rossi, Elisa Stipa, et al.
Pageof 9